这是一篇来自已证抗体库的有关
人类 MED12的综述，是根据7篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合MED12 抗体。
MED12 同义词: ARC240; CAGH45; FGS1; HOPA; MED12S; OHDOX; OKS; OPA1; TNRC11; TRAP230; mediator of RNA polymerase II transcription subunit 12; CAG repeat protein 45; OPA-containing protein; activator-recruited cofactor 240 kDa component; human opposite paired; mediator of RNA polymerase II transcription, subunit 12 homolog; thyroid hormone receptor-associated protein complex 230 kDa component; thyroid hormone receptor-associated protein, 230 kDa subunit; trinucleotide repeat containing 11 (THR-associated protein, 230 kDa subunit); trinucleotide repeat-containing gene 11 protein
Bethyl
| 兔 多克隆 | - 免疫沉淀; 人类; 图 5a
- 免疫印迹; 人类; 图 1c
| Bethyl MED12抗体（Bethyl Lab, A300-774A)被用于被用于免疫沉淀在人类样品上 (图 5a) 和 被用于免疫印迹在人类样品上 (图 1c). Hum Mol Genet (2017) ncbi |
| 兔 多克隆 | | Bethyl MED12抗体（Bethyl Lab, A300-774A)被用于被用于免疫印迹在人类样品上. EMBO J (2015) ncbi |
| 兔 多克隆 | | Bethyl MED12抗体（Bethyl, A300-774A)被用于被用于ChIP-Seq在小鼠样品上. Cell (2014) ncbi |
| 兔 多克隆 | - 免疫沉淀; 小鼠; 图 2c
- 免疫印迹; 小鼠; 1:500; 图 2c
| Bethyl MED12抗体（Bethyl, A300-774A)被用于被用于免疫沉淀在小鼠样品上 (图 2c) 和 被用于免疫印迹在小鼠样品上浓度为1:500 (图 2c). Nat Cell Biol (2014) ncbi |
| 兔 多克隆 | | Bethyl MED12抗体（Bethyl, A300-774A)被用于被用于染色质免疫沉淀
在人类样品上. Cell (2014) ncbi |
| 兔 多克隆 | - 免疫细胞化学; 人类; 1:50; 图 5
- 免疫组化; 人类; 1:50; 图 1
- 免疫印迹; 人类; 1:50; 图 5
| Bethyl MED12抗体（Bethyl Laboratories, A300-774A)被用于被用于免疫细胞化学在人类样品上浓度为1:50 (图 5), 被用于免疫组化在人类样品上浓度为1:50 (图 1) 和 被用于免疫印迹在人类样品上浓度为1:50 (图 5). Endocr Relat Cancer (2014) ncbi |
赛信通（上海）生物试剂有限公司
| 兔 多克隆 | - 免疫印迹基因敲除验证; 人类; 1:1000; 图 s10
| 赛信通（上海）生物试剂有限公司 MED12抗体（Cell Signaling, 4529S)被用于被用于免疫印迹基因敲除验证在人类样品上浓度为1:1000 (图 s10). Science (2014) ncbi |
Donnio L, Bidon B, Hashimoto S, May M, Epanchintsev A, Ryan C,
et al. MED12-related XLID disorders are dose-dependent of immediate early genes (IEGs) expression. Hum Mol Genet. 2017;26:2062-2075
pubmed 出版商 Yao X, Tang Z, Fu X, Yin J, Liang Y, Li C,
et al. The Mediator subunit MED23 couples H2B mono-ubiquitination to transcriptional control and cell fate determination. EMBO J. 2015;34:2885-902
pubmed 出版商 Qian J, Wang Q, Dose M, Pruett N, Kieffer Kwon K, Resch W,
et al. B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity. Cell. 2014;159:1524-37
pubmed 出版商 Li N, Fassl A, Chick J, Inuzuka H, Li X, Mansour M,
et al. Cyclin C is a haploinsufficient tumour suppressor. Nat Cell Biol. 2014;16:1080-91
pubmed 出版商 Trimarchi T, Bilal E, Ntziachristos P, Fabbri G, Dalla Favera R, Tsirigos A,
et al. Genome-wide mapping and characterization of Notch-regulated long noncoding RNAs in acute leukemia. Cell. 2014;158:593-606
pubmed 出版商 Shaikhibrahim Z, Offermann A, Braun M, Menon R, Syring I, Nowak M,
et al. MED12 overexpression is a frequent event in castration-resistant prostate cancer. Endocr Relat Cancer. 2014;21:663-75
pubmed 出版商 Shalem O, Sanjana N, Hartenian E, Shi X, Scott D, Mikkelson T,
et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science. 2014;343:84-87
pubmed 出版商
